Active surveillance is safe strategy for favourable-risk prostate cancer
Added: Wednesday 20 May 2015
Active surveillance appears to be a safe strategy for managing prostate cancer in carefully-selected patients whose cancer is favourable-risk. The results of the study showing this were presented at the recent Annual Meeting of the American Urological Association.
In order to be able to see the content from the www.medscape.com pages, please create first a free account at following link: